Current Fellows

First Year Fellows

Afroditi Boulougoura, MDAfroditi Boulougoura, MD

Afroditi Boulougoura graduated from the University of Athens Medical School in Greece. She then moved to the US, where she worked as a Research Fellow at the National Institutes of Health, initially on autoimmunity in Type 1 Diabetes Mellitus and subsequently on inflammatory conditions in primary and secondary immunodeficiency syndromes. She was the first author of a Phase I Clinical Trial studying a novel phosphodiesterase 4 inhibitor in patients with HIV. She completed her Internal Medicine residency at MedStar Georgetown University Hospital in Washington, D.C. Academically, she is interested in systemic lupus erythematosus, rheumatoid arthritis and scleroderma. On a personal level, she loves hiking, cooking, and barre fitness.


Dan Magliulo, MDDan Magliulo, MD

Dan Magliulo was born and raised in Kailua, Hawaii. He graduated from the University of Hawaii Medical School as a member of AΩA Honor Medical Society and completed his residency in Internal Medicine at Beth Israel Deaconess Medical Center. He actively works in clinical research in the areas of gout treatment and lupus lymphadenitis. His academic interests include musculoskeletal ultrasound, quality improvement, and medical education. In his free time, he enjoys cooking, playing with his cats, and tending to his bonsai tree collection.

Second Year Fellows

Jose Rubio MDJose Rubio, MD

Jose Rubio was born and raised in Guayaquil, Ecuador. After obtaining his medical degree at the University of Guayaquil, he completed Internal Medicine Residency at MetroWest Medical Center in Framingham, MA. Then, he served one more year at MetroWest Medical Center, as Chief Medical Resident, improving his skills as an educator and a leader. Throughout his fellowship, he demonstrated interest in SLE and preclinical lupus. He published a study on the usefulness of the new classification criteria in diagnosing lupus using the BIDMC lupus cohort and performed a literature review of the role of interferon activity in pre-clinical SLE. Currently, he is participating in the Clinical and Translation Research Academy program at Harvard Catalyst where he is studying the role of CD8+CD38 T cells as a predictor of infection risk in patients with SLE. He plans to continue a career in academia with a focus in clinical research, mainly exploring predictive biomarkers in evolving connective tissue diseases. In his free time, he enjoys outdoor activities, soccer, and cooking.

Third Year Fellows

Stefanie D. Wade, MDStefanie D. Wade, MD

Stefanie Wade was raised in Vancouver, Canada and received her Bachelor of Science from the University of Victoria and MD from St. George's University. She developed an interest in quality improvement and medical education during her residency training and Chief Medical Residency at the University of Connecticut. As a rheumatology fellow, Stefanie pursued formal training in medical education through the Clinician Educator Track at BIDMC and is currently conducting an education-related quality improvement project within the division. She also is involved in clinical outcomes and translational research in rheumatology. She presented her work on rituximab-induced hypogammaglobulinemia at the 2019 ACR Annual Meeting. She is pursuing further clinical and research training in rheumatology through a third year of subspecialty training at BIDMC. She enjoys traveling, soccer, and skiing.